JUN 10, 2016 08:00 AM PDT

Lupus Anticoagulant (LA): Choosing the Right Testing Strategy for Your Laboratory

C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Director, Coagulation Consultative Service Director, Pathology and Laboratory Medicine Residency Program, Associate Professor, Cedars Sinai Medical Center
      Dr. Oksana Volod is a pathologist in West Hollywood, California and is affiliated with Cedars-Sinai Medical Center. She received her medical degree from Uzhhorod National University Faculty of Medicine and has been in practice for more than 20 years. She is one of 46 doctors at Cedars-Sinai Medical Center who specialize in Pathology.


    Lupus anticoagulants are markers of prothrombotic potential which may be indicative of underlying antiphospholipid syndrome (aPS) requiring treatment with ongoing anticoagulants.  The purpose of this educational program is to update healthcare professionals regarding advancements in Lupus Anticoagulant (LA) testing. Current LA diagnostic guidelines, clinical evidence regarding LA significance, assay selection, and anticoagulant drugs interfering with LA testing will be discussed, along with clinical cases of high interest.

    • Describe role of Lupus Anticoagulant (LA) in Antiphospholipid Syndrome (APS).
    • Define current ISTH and CLSI Guidelines, identify tests, and define patient selection for appropriate LA work up.
    • Recognize medications that may cause false positive LA results.
    • Evaluate the right testing strategy for LA testing.
    • Correlate LA and APS to specific clinical cases.

    Show Resources
    Show Resources